Literature DB >> 21494764

Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort.

Olivia Boeuf-Cazou1, Bienvenu Bongue, David Ansiau, Jean-Claude Marquié, Maryse Lapeyre-Mestre.   

Abstract

PURPOSE: Results from a number of studies have suggested a relationship between cognitive alteration and benzodiazepine use in the elderly. The aim of this study was to determine the impact of benzodiazepine use on cognitive functions in a young adult population.
METHODS: This study included 1,019 French salaried workers from the VISAT (Aging, Health and Work) cohort whose objective was to determine the long-term impact of working conditions on health and aging. Data were collected during interviews by occupational physicians in 1996, 2001 and 2006. Cognitive function was assessed using five cognitive tests (immediate free recall test, delayed free recall test, recognition test, Digit Symbol Substitution Subtest and visual search speed test). Cognitive scores obtained after a 10-year follow-up were investigated among three categories of benzodiazepine users, namely, non-users, occasional users and long-term users, using analysis of covariance models adjusted for several potential confounders in men and women separately.
RESULTS: In the course of the 10 year-follow-up, 3.9% of subjects were defined as occasional users of benzodiazepine and 7.5% as long-term users. The analysis revealed a significant alteration of long-term memory in women whereas there was no significant association in men.
CONCLUSIONS: Long-term use of benzodiazepine leads to specific impairment in long-term memory only in women.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21494764     DOI: 10.1007/s00228-011-1047-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  34 in total

1.  [Taking drugs in the working environment: a study in a sample of 2106 workers in the Toulouse metropolitan area].

Authors:  Maryse Lapeyre-Mestre; Patrick Sulem; Michel Niezborala; Théodore Bienvenu Ngoundo-Mbongue; Dominique Briand-Vincens; Pierre Jansou; Yannick Bancarel; Evelyne Chastan; Jean-Louis Montastruc
Journal:  Therapie       Date:  2004 Nov-Dec       Impact factor: 2.070

Review 2.  Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies.

Authors:  Helene Verdoux; Rajaa Lagnaoui; Bernard Begaud
Journal:  Psychol Med       Date:  2005-03       Impact factor: 7.723

3.  The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?

Authors:  E J M Bierman; H C Comijs; C M Gundy; C Sonnenberg; C Jonker; A T F Beekman
Journal:  Int J Geriatr Psychiatry       Date:  2007-12       Impact factor: 3.485

4.  Relation between body mass index and cognitive function in healthy middle-aged men and women.

Authors:  M Cournot; J C Marquié; D Ansiau; C Martinaud; H Fonds; J Ferrières; J B Ruidavets
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

5.  Benzodiazepine use among the elderly in the community.

Authors:  M Kirby; A Denihan; I Bruce; A Radic; D Coakley; B A Lawlor
Journal:  Int J Geriatr Psychiatry       Date:  1999-04       Impact factor: 3.485

6.  Benzodiazepine use and risk of dementia: a nested case-control study.

Authors:  Rajaa Lagnaoui; Bernard Bégaud; Nicholas Moore; Anicet Chaslerie; Annie Fourrier; Luc Letenneur; Jean François Dartigues; Yola Moride
Journal:  J Clin Epidemiol       Date:  2002-03       Impact factor: 6.437

7.  Sleeping tablet consumption, self reported quality of sleep, and working conditions. Group of Occupational Physicians of APSAT.

Authors:  M C Jacquinet-Salord; T Lang; C Fouriaud; I Nicoulet; A Bingham
Journal:  J Epidemiol Community Health       Date:  1993-02       Impact factor: 3.710

8.  Benzodiazepine use and cognitive function among community-dwelling elderly.

Authors:  J T Hanlon; R D Horner; K E Schmader; G G Fillenbaum; I K Lewis; W E Wall; L R Landerman; C F Pieper; D G Blazer; H J Cohen
Journal:  Clin Pharmacol Ther       Date:  1998-12       Impact factor: 6.875

9.  Depression and anxiety in hypothyroidism.

Authors:  M M Demet; B Ozmen; A Deveci; S Boyvada; H Adiguzel; O Aydemir
Journal:  West Indian Med J       Date:  2003-09       Impact factor: 0.171

10.  Social inequalities and correlates of psychotropic drug use among young adults: a population-based questionnaire study.

Authors:  Nearkasen Chau; Michèle Baumann; Bruno Falissard; Marie Choquet
Journal:  Int J Equity Health       Date:  2008-01-19
View more
  11 in total

1.  Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition.

Authors:  Yuhai Zhang; Xiao-Hua Zhou; Dana H Meranus; Linbo Wang; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

2.  Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study.

Authors:  Angela Federico; Stefano Tamburin; Alice Maier; Marco Faccini; Rebecca Casari; Laura Morbioli; Fabio Lugoboni
Journal:  Neurol Sci       Date:  2016-10-11       Impact factor: 3.307

3.  Detoxification Improves Multidomain Cognitive Dysfunction in High-Dose Benzodiazepine Abusers.

Authors:  Angela Federico; Fabio Lugoboni; Elisa Mantovani; Alice Martini; Laura Morbioli; Rebecca Casari; Marco Faccini; Stefano Tamburin
Journal:  Front Neurosci       Date:  2020-07-21       Impact factor: 4.677

4.  Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!

Authors:  François Montastruc; Virginie Gardette; Christelle Cantet; Antoine Piau; Maryse Lapeyre-Mestre; Bruno Vellas; Jean-Louis Montastruc; Sandrine Andrieu
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

5.  Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol.

Authors:  Carlos A Soria; Carolina Remedi; Daniel A Núñez; Luciana D'Alessio; Emilio J A Roldán
Journal:  BMJ Open       Date:  2015-07-14       Impact factor: 2.692

Review 6.  Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects.

Authors:  Tianze Cheng; Dominique Marie Wallace; Benjamin Ponteri; Mahir Tuli
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-23       Impact factor: 2.570

7.  Polysubstance Use Patterns Among High Dose Benzodiazepine Users: A Latent Class Analysis and Differences Between Male and Female Use.

Authors:  Lorenzo Zamboni; Igor Portoghese; Alessio Congiu; Thomas Zandonai; Rebecca Casari; Francesca Fusina; Anna Bertoldi; Fabio Lugoboni
Journal:  Front Psychiatry       Date:  2022-01-25       Impact factor: 4.157

8.  Benzodiazepine use and risk of dementia: prospective population based study.

Authors:  Sophie Billioti de Gage; Bernard Bégaud; Fabienne Bazin; Hélène Verdoux; Jean-François Dartigues; Karine Pérès; Tobias Kurth; Antoine Pariente
Journal:  BMJ       Date:  2012-09-27

9.  Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia.

Authors:  Miren Ettcheto; Jordi Olloquequi; Elena Sánchez-López; Oriol Busquets; Amanda Cano; Patricia Regina Manzine; Carlos Beas-Zarate; Rubén D Castro-Torres; Maria Luisa García; Mónica Bulló; Carme Auladell; Jaume Folch; Antonio Camins
Journal:  Front Aging Neurosci       Date:  2020-01-08       Impact factor: 5.750

Review 10.  Is Long-Term Benzodiazepine Use a Risk Factor for Cognitive Decline? Results of a Systematic Review.

Authors:  Danilo Nader; Linda Gowing
Journal:  J Addict       Date:  2020-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.